Alimera Sciences (Nasdaq: ALIM) announced that the Swedish Medical Products Agency has granted marketing authorization to ILUVIEN for the treatment ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE